“Faecal Microbiota Composition and Metabolomic Profiles as Diagnostic Markers in Patients with Irritable Bowel Syndrome: A Review”, AGDD, vol. 9, no. 1, pp. 17–21, Jul. 2026, doi: 10.5281/zenodo.22207631.